Daiwa Securities Group Inc. Ngm Biopharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$20.15 - $26.19 $2,397 - $3,116	119 Added 81.51%	265 $6,000
Q1 2021 May 03, 2021	BUY	$24.99 - $31.93 $399 - $510	16 Added 12.31%	146 $4,000
Q4 2020 Feb 04, 2021	SELL	$16.21 - $31.44 $3,987 - $7,734	-246 Reduced 65.43%	130 $4,000
Q4 2019 Jan 31, 2020	BUY	$9.97 - $20.28 $3,748 - $7,625	376 New	376 $7,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.